JP2013515270A - 前立腺癌の代謝学的プロファイリング - Google Patents

前立腺癌の代謝学的プロファイリング Download PDF

Info

Publication number
JP2013515270A
JP2013515270A JP2012546198A JP2012546198A JP2013515270A JP 2013515270 A JP2013515270 A JP 2013515270A JP 2012546198 A JP2012546198 A JP 2012546198A JP 2012546198 A JP2012546198 A JP 2012546198A JP 2013515270 A JP2013515270 A JP 2013515270A
Authority
JP
Japan
Prior art keywords
cancer
acid
sample
prostate cancer
prostate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012546198A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013515270A5 (enExample
Inventor
エム． チンナイヤン，アルル
ラジェンディラン，セッケルネイク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan Ann Arbor
Original Assignee
University of Michigan System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan System filed Critical University of Michigan System
Publication of JP2013515270A publication Critical patent/JP2013515270A/ja
Publication of JP2013515270A5 publication Critical patent/JP2013515270A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/493—Physical analysis of biological material of liquid biological material urine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
JP2012546198A 2009-12-22 2010-12-22 前立腺癌の代謝学的プロファイリング Pending JP2013515270A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28920609P 2009-12-22 2009-12-22
US61/289,206 2009-12-22
PCT/US2010/061811 WO2011087845A2 (en) 2009-12-22 2010-12-22 Metabolomic profiling of prostate cancer

Publications (2)

Publication Number Publication Date
JP2013515270A true JP2013515270A (ja) 2013-05-02
JP2013515270A5 JP2013515270A5 (enExample) 2014-01-23

Family

ID=44151645

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012546198A Pending JP2013515270A (ja) 2009-12-22 2010-12-22 前立腺癌の代謝学的プロファイリング

Country Status (5)

Country Link
US (2) US20110151497A1 (enExample)
EP (1) EP2517022A4 (enExample)
JP (1) JP2013515270A (enExample)
CN (1) CN102893157A (enExample)
WO (1) WO2011087845A2 (enExample)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101462206B1 (ko) 2013-06-26 2014-11-20 한국과학기술연구원 트립토판 대사 변화를 이용한 위암 진단용 기초 정보 제공 방법
JP2015049050A (ja) * 2013-08-29 2015-03-16 花王株式会社 排尿障害のバイオマーカー
KR20150042553A (ko) * 2013-10-11 2015-04-21 주식회사 씨스퀘어 사르코신 대사산물 중 과산화물을 이용한 전립선암 진단 시험지, 그 제조 방법 및 이를 이용한 전립선암 진단 방법
JP2017533413A (ja) * 2014-09-10 2017-11-09 アイディーシージーエス クリニカ デ ジアギノースチコス メディコス リミターダ 乳癌を評価するためのバイオマーカー
WO2017213246A1 (ja) * 2016-06-10 2017-12-14 株式会社日立製作所 尿中代謝物による疾病診断法
JP2018194556A (ja) * 2012-02-23 2018-12-06 学校法人慶應義塾 併用抗がん剤の感受性判定マーカー
JP2019525198A (ja) * 2016-05-29 2019-09-05 深▲じぇん▼市▲絵▼云生物科技有限公司 肝疾患関連バイオマーカーおよびその使用方法
JP2021531464A (ja) * 2018-07-17 2021-11-18 エヌアイビー バイオテック エセ．エレ．エレ． 尿中バイオマーカーにより前立腺癌をｉｎ ｖｉｔｒｏで診断する方法
WO2022149487A1 (ja) * 2021-01-07 2022-07-14 住友化学株式会社 前立腺がんの罹患の可能性を検査する方法

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6280997B1 (ja) * 2016-10-31 2018-02-14 株式会社Preferred Networks 疾患の罹患判定装置、疾患の罹患判定方法、疾患の特徴抽出装置及び疾患の特徴抽出方法
CN106770873B (zh) * 2017-01-19 2019-02-19 中国人民解放军第四军医大学 一种膀胱癌诊断标志物及其应用和诊断试剂盒
CN108344830B (zh) * 2017-01-22 2020-10-16 中国科学院大连化学物理研究所 用于诊断前列腺癌的尿样组合标志物及检测试剂盒
KR102077058B1 (ko) * 2017-09-21 2020-02-13 연세대학교 산학협력단 대사체 프로파일링을 이용한 유방암의 예후 또는 위험도를 평가하는 방법 및 키트
CN108414661B (zh) * 2018-03-13 2020-04-21 中国医科大学 一种检测生物样品中氨含量的衍生化气相色谱-质谱方法
EP3803390B1 (en) * 2018-06-01 2024-05-01 Lewis, Ian Andrew Method for detecting urinary tract infections and sample analysis
KR102405789B1 (ko) * 2018-08-24 2022-06-07 고려대학교 세종산학협력단 키누레닌 경로 대사체를 포함하는 전립선암 진단용 바이오마커 조성물
EP3629021A1 (en) * 2018-09-26 2020-04-01 Euroimmun Medizinische Labordiagnostika AG Diagnosis of a neuroautoimmune disease
KR20210030883A (ko) * 2019-09-10 2021-03-18 고려대학교 세종산학협력단 인돌아민 2,3-이산소화 효소를 포함하는 전립선암 진단용 마커
US20210333280A1 (en) * 2020-04-23 2021-10-28 YatHing Biotechnology Company Limited Methods related to the diagnosis of prostate cancer
US20230384316A1 (en) * 2020-10-20 2023-11-30 Baylor College Of Medicine Multiplex metabolic markers in plasma for early detection of african american prostate cancer
CN114324674A (zh) * 2022-01-21 2022-04-12 苏州南医大创新中心 一种精液中与无精子症有关的分子标志物及其检测方法和应用
CN114487217B (zh) * 2022-02-14 2024-06-25 广州市番禺区中心医院 一种区分前列腺癌和良性前列腺增生的标志物及试剂盒
CN114544812B (zh) * 2022-02-18 2023-06-30 复旦大学附属中山医院 一种代谢组合式标志物在诊断哮喘中的应用
CN116465920B (zh) * 2023-04-03 2023-11-10 汕头大学医学院 用于诊断食管癌的代谢标志物
CN116106535B (zh) * 2023-04-11 2023-08-11 南京品生医学检验实验室有限公司 生物标志物组合在制备乳腺癌预测产品中的应用
TW202528739A (zh) * 2023-09-05 2025-07-16 國立臺灣大學 用於前列腺癌的生物標記
DE102023125870A1 (de) * 2023-09-25 2025-03-27 Numares Ag Verwendung eines Markersets für die Diagnostik des Prostatakarzinoms

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007066216A2 (en) * 2005-12-09 2007-06-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) Fatty acids profile correlated to the propensity or risk of breast cancer
JP2010537170A (ja) * 2007-08-16 2010-12-02 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 前立腺癌の代謝プロファイリング法
JP5297379B2 (ja) * 2006-09-19 2013-09-25 メタボロン、インコーポレイテッド 前立腺癌のバイオマーカー及びそれを使用する方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020139A (en) * 1995-04-25 2000-02-01 Oridigm Corporation S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
US6866837B2 (en) * 1998-06-05 2005-03-15 Mallinckrodt Inc. Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
US7329489B2 (en) * 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
WO2001078652A2 (en) * 2000-04-14 2001-10-25 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US20050181375A1 (en) * 2003-01-10 2005-08-18 Natasha Aziz Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
US20070078093A1 (en) * 2003-10-16 2007-04-05 The Administrators Of The Tulane Educational Fund Methods and compositions for treating cancer
US20070055456A1 (en) * 2005-08-31 2007-03-08 Daniel Raftery NMR method for differentiating complex mixtures
CN101454331A (zh) * 2006-03-24 2009-06-10 菲诺梅诺米发现公司 有效用于诊断前列腺癌的生物标记，及其方法
US20090075284A1 (en) * 2006-09-19 2009-03-19 The Regents Of The University Of Michigan Metabolomic profiling of prostate cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007066216A2 (en) * 2005-12-09 2007-06-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) Fatty acids profile correlated to the propensity or risk of breast cancer
JP5297379B2 (ja) * 2006-09-19 2013-09-25 メタボロン、インコーポレイテッド 前立腺癌のバイオマーカー及びそれを使用する方法
JP2010537170A (ja) * 2007-08-16 2010-12-02 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 前立腺癌の代謝プロファイリング法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6014033430; Ｋｉｎｇｓｎｏｒｔｈ　ＡＮ: 'Ｐｏｌｙａｍｉｎｅｓ　ｉｎ　ｂｒｅａｓｔ　ｃａｎｃｅｒ' Ｂｒｉｔｉｓｈ　Ｊｏｕｒｎａｌ　ｏｆ　Ｓｕｒｇｅｒｙ ７１／　５, 1984, ３５２-３５６ *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018194556A (ja) * 2012-02-23 2018-12-06 学校法人慶應義塾 併用抗がん剤の感受性判定マーカー
US9304135B2 (en) 2013-06-26 2016-04-05 Korea Institute Of Science And Technology Method for diagnosing stomach cancer using change of tryptophan metabolism
KR101462206B1 (ko) 2013-06-26 2014-11-20 한국과학기술연구원 트립토판 대사 변화를 이용한 위암 진단용 기초 정보 제공 방법
JP2015049050A (ja) * 2013-08-29 2015-03-16 花王株式会社 排尿障害のバイオマーカー
KR20150042553A (ko) * 2013-10-11 2015-04-21 주식회사 씨스퀘어 사르코신 대사산물 중 과산화물을 이용한 전립선암 진단 시험지, 그 제조 방법 및 이를 이용한 전립선암 진단 방법
KR101955430B1 (ko) 2013-10-11 2019-03-11 주식회사 씨스퀘어 사르코신 대사산물 중 과산화물을 이용한 전립선암 진단 시험지, 그 제조 방법 및 이를 이용한 전립선암 진단에 필요한 정보를 제공하는 방법
JP2017533413A (ja) * 2014-09-10 2017-11-09 アイディーシージーエス クリニカ デ ジアギノースチコス メディコス リミターダ 乳癌を評価するためのバイオマーカー
JP2019525198A (ja) * 2016-05-29 2019-09-05 深▲じぇん▼市▲絵▼云生物科技有限公司 肝疾患関連バイオマーカーおよびその使用方法
JP7036805B2 (ja) 2016-05-29 2022-03-15 深▲じぇん▼市▲絵▼云生物科技有限公司 肝疾患関連バイオマーカーおよびその使用方法
JPWO2017213246A1 (ja) * 2016-06-10 2018-11-08 株式会社日立製作所 尿中代謝物による疾病診断法
WO2017213246A1 (ja) * 2016-06-10 2017-12-14 株式会社日立製作所 尿中代謝物による疾病診断法
JP2021531464A (ja) * 2018-07-17 2021-11-18 エヌアイビー バイオテック エセ．エレ．エレ． 尿中バイオマーカーにより前立腺癌をｉｎ ｖｉｔｒｏで診断する方法
JP7619934B2 (ja) 2018-07-17 2025-01-22 エヌアイビー バイオテック エセ．エレ．エレ． 尿中バイオマーカーにより前立腺癌をｉｎ ｖｉｔｒｏで診断する方法
WO2022149487A1 (ja) * 2021-01-07 2022-07-14 住友化学株式会社 前立腺がんの罹患の可能性を検査する方法
JPWO2022149487A1 (enExample) * 2021-01-07 2022-07-14
JP7769179B2 (ja) 2021-01-07 2025-11-13 住友化学株式会社 前立腺がんの罹患の可能性を検査する方法

Also Published As

Publication number Publication date
CN102893157A (zh) 2013-01-23
EP2517022A4 (en) 2013-07-10
EP2517022A2 (en) 2012-10-31
WO2011087845A2 (en) 2011-07-21
WO2011087845A3 (en) 2011-11-17
US20130261022A1 (en) 2013-10-03
US20110151497A1 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
JP2013515270A (ja) 前立腺癌の代謝学的プロファイリング
JP5406187B2 (ja) 前立腺癌の代謝プロファイリング法
US11493516B2 (en) Biomarkers for assessing breast cancer
US20090075284A1 (en) Metabolomic profiling of prostate cancer
JP6427137B2 (ja) 前立腺癌を診断する手段と方法
JP6021187B2 (ja) 自閉症の代謝バイオマーカー
EP2249161A1 (en) Method of diagnosing asphyxia
JP2007527001A (ja) がんに関する診断マーカー
CN101313220A (zh) 肝细胞癌的分子标志物及其应用
Fan et al. Identification of the up-regulation of TP-alpha, collagen alpha-1 (VI) chain, and S100A9 in esophageal squamous cell carcinoma by a proteomic method
Drago et al. A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer
Sun et al. Characterization of the liver tissue interstitial fluid (TIF) proteome indicates potential for application in liver disease biomarker discovery
US11047860B2 (en) Protein quantitation in multicellular tissue specimens
US10908162B2 (en) Methods related to volatile compounds in genitourinary cancers
Silva et al. Pre-estrus progesterone does not affect post-estrus luminal metabolome in cross-bred beef cows
JP2011512149A (ja) ガンの検出の方法および手法
Wang et al. Complex changes in the liver mitochondrial proteome of short chain acyl-CoA dehydrogenase deficient mice
RU2445000C2 (ru) Способ диагностики онкологических заболеваний предстательной железы на основе ацилкарнитина и арахидоноил амина
WO2021225525A1 (en) A biomarker for brown fat activity detection
Liu et al. BIOM-13. DEVELOPMENT AND VALIDATION OF AN LC-MS/MS ASSAY TO MEASURE GLUTATHIONE, GLUTATHIONE DISULFIDE, CYSTEINE, AND CYSTINE IN HUMAN BRAIN AND HUMAN GLIOBLASTOMA
Pavlov et al. Integral role of metabolic profiling in patients with prostate cancer
Matthiesen et al. Profiling of urinary extracellular vesicle protein signatures from patients with cribriform and intraductal prostate carcinoma in a cross-sectional study
Li et al. Diazo-carboxyl click chemistry enables rapid and sensitive quantification of carboxylic acid metabolites
Batsios et al. BIOM-10. PRECLINICAL PLATFORM FOR THE IDENTIFICATION OF DEUTERIUM MAGNETIC RESONANCE SPECTROSCOPY-BASED BIOMARKERS OF BRAIN TUMOR METABOLISM
HK1143418B (en) Metabolomic profiling of prostate cancer

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131128

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20131128

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140724

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140819

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150210